Cite
HARVARD Citation
He, J. et al. (2018). Antitumor and radiosensitizing effects of SKLB-163, a novel benzothiazole-2-thiol derivative, on nasopharyngeal carcinoma by affecting the RhoGDI/JNK-1 signaling pathway. Radiotherapy and oncology. 129 (1), pp. 30-37. [Online].